A b s t r a c tIntroduction: Latent autoimmune diabetes in adults (LADA) is a slowly developing form of autoimmune diabetes characterized by the presence of type 1 diabetes-associated autoantibody. The aim of this study was to determine the incidence and characteristics of LADA in a population-based cohort of Polish patients with newly-diagnosed diabetes. Material and methods: The study cohort was taken from the resident population of the city Białystok, Poland, during the period 1 January to 31 December 2003, aged 20-64 years. During this period we identified 231 cases of diabetes. We measured glutamic acid decarboxylase (GADA) and insulin antibody (IAA), insulin, C peptide and glycated hemoglobin (HbA 1c ). Diagnosis of LADA was made according to Immunology Diabetes Society and Action LADA criteria. Results: The incidence of LADA was 10 per year per 100 000 people. The proportion of patients with LADA was 8.9% among newly diagnosed cases with diabetes. Patients with LADA were younger at diagnosis (48.5 ±9.4 years vs. 54.8 ±10.6 years, p < 0.01), had lower body mass index (26.9 ±9.3 kg/m 2 vs. 29.5 ±5.2 kg/m 2 , p < 0.05), C peptide (126 ±127 pmol/l vs. 446 ±592 pmol/l, p < 0.001), and were less insulin resistant (HOMA IR 0.94 ±0.85 vs. 3.6 ±4.4, p < 0.001) compared to patients with type 2 diabetes. Glycated hemoglobin and fasting glucose were similar in patients with LADA and type 2 diabetes. Conclusions: In addition to GAD, anti-insulin antibodies are useful for diagnosing autoimmune diabetes in adults. Patients with LADA have similar glucose control parameters (HbA 1c ) compared to patients with type 2 diabetes, although they are usually younger and have a lower body mass index. Patients with LADA make up a significant proportion of newly diagnosed people with diabetes mellitus in a Polish population.
Aging processes in a body inevitably lead to changes which may decrease the quality of life of the elderly. Dynapenia is a phenomenon which is still not well known and needs to be studied in the population. The aim of the research was to determine the effects of lifestyle on the risk of developing dynapenia in post-menopausal women. The study included 46 females aged 71.4 ±5.6 living in the town of Wysokie Mazowieckie. Basic body dimensions and body composition elements were assessed with the use of anthropometry and bioelectrical impedance analysis (BIA). A direct interview method with the use of the modified Sedentary Behavior Questionnaire (SBQ) was applied. In order to assess the prevalence of dynapenia, handgrip strength was measured with the use of hydraulic dynamometer. Physical activity was assessed with the use of a pedometer. The respondents’ nutrition was examined in an interview concerning their diet from the 24 hours preceding the examination according to the methodology of Food and Nutrition Institute (FNI). The intake of energy and nutritional elements in a diet was calculated with using DIETA 5.0 computer software. Dynapenia was diagnosed in 21.7% of the examined women. The women with dynapenia had significantly bigger waist and hip circumferences and higher BMI (p<0.05) as well as significantly weaker hand muscles than healthy women (p<0.001). Females with dynapenia spent significantly more time in a sedentary position, i.e. talking on the phone, participating in religious rituals or watching TV (p<0.05) compared to women without dynapenia. No significant differences concerning the diet of women with and without dynapenia were revealed. Physical activity may significantly decrease the risk of dynapenia among women over 60 years of age. Furher research is needed to assess the risk of dynapenia and methods of its prevention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.